Anthony is the CEO and co-founder of Awakn Life Sciences (CSE: AWKN), a clinical-stage biotechnology company focused on developing therapeutics for substance use and mental health disorders. He also serves as the CEO of Graft Polymer (UK) Plc (LON: GPL), a company specializing in innovative biopolymer drug delivery systems. In addition, Anthony is a non-executive director at Empowerment Plus, an Irish non-profit supporting young people and families at risk.
Before moving into the healthcare sector, Anthony accumulated over a decade of experience in financial services. He spent ten years in international strategy and commercial leadership roles at Aon Plc and worked at Merrill Lynch and Bank of Ireland for five years. Anthony holds an MBA and an MSc from University College Dublin (UCD).
Sign Up for Newsletter
MAIN OFFICE
Awakn Life Sciences Corp
301-217 Queen St. W
Toronto, Ontario M5V 0R2
Canada
© 2023 Awakn Life Sciences Corp | Privacy Policy | Disclaimer